Greenwich LifeSciences, Inc.Greenwich LifeSciences, Inc.Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪183.24 M‬USD
−0.81USD
‪−8.89 M‬USD
0.00USD
‪5.92 M‬
Beta (1Y)
1.40
Employees (FY)
7
Change (1Y)
+1 +16.67%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−1.27 M‬USD

About Greenwich LifeSciences, Inc.


CEO
Snehal S. Patel
Headquarters
Stafford
Founded
2006
FIGI
BBG00V6PT8C7
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GLSI is 14.30 USD — it has increased by 2.88% in the past 24 hours. Watch Greenwich LifeSciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Greenwich LifeSciences, Inc. stocks are traded under the ticker GLSI.
GLSI stock has risen by 9.42% compared to the previous week, the month change is a 1.31% rise, over the last year Greenwich LifeSciences, Inc. has showed a 19.17% increase.
We've gathered analysts' opinions on Greenwich LifeSciences, Inc. future price: according to them, GLSI price has a max estimate of 38.00 USD and a min estimate of 38.00 USD. Watch GLSI chart and read a more detailed Greenwich LifeSciences, Inc. stock forecast: see what analysts think of Greenwich LifeSciences, Inc. and suggest that you do with its stocks.
GLSI reached its all-time high on Dec 9, 2020 with the price of 158.07 USD, and its all-time low was 3.26 USD and was reached on Nov 4, 2020. View more price dynamics on GLSI chart.
See other stocks reaching their highest and lowest prices.
GLSI stock is 5.40% volatile and has beta coefficient of 1.40. Track Greenwich LifeSciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Greenwich LifeSciences, Inc. there?
Today Greenwich LifeSciences, Inc. has the market capitalization of ‪183.24 M‬, it has increased by 3.26% over the last week.
Yes, you can track Greenwich LifeSciences, Inc. financials in yearly and quarterly reports right on TradingView.
Greenwich LifeSciences, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
GLSI net income for the last quarter is ‪−2.67 M‬ USD, while the quarter before that showed ‪−2.61 M‬ USD of net income which accounts for −2.38% change. Track more Greenwich LifeSciences, Inc. financial stats to get the full picture.
No, GLSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is Greenwich LifeSciences, Inc. on this list?
Like other stocks, GLSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Greenwich LifeSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Greenwich LifeSciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Greenwich LifeSciences, Inc. stock shows the buy signal. See more of Greenwich LifeSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.